Haoxi Health Technology Limited Class A (HAO)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Dilution Risk
MEDIUM DILUTION RISKDilution score: 43/100 (MEDIUM), 29.2 months cash
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: ?% of float, squeeze risk: LOW
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Haoxi Health Technology Limited Announces 1-For-20 Reverse Share Split
- Haoxi Health Technology Signs Strategic Cooperation to Develop AI Digital Marketing System
- Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System
- Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
- Haoxi Health Technology Ltd Announces $4 Million Registered Direct Offering
- Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split
- Univest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)
- Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Haoxi Health Technology Limited Class A.
Full HAO Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.